Lymphangiogenesis and Axillary Lymph Node Metastases Correlated with VEGF-C Expression in Two Immunocompetent Mouse Mammary Carcinoma Models

Figure 4

Immunohistochemistry of LYVE-1 in BJMC338 tumors (a, c, e, and g) and BJMC3879 tumors (b, d, f, and h) at 4 weeks (a and b), 6 weeks (c and d), 8 weeks (e and f), and 10 weeks postinoculation (g and h). Note the upregulation of LYVE-1 in BJMC3879 tumors.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)